Stelios Spanos
Directeur/Membre du Conseil chez Pharmathen Pharmaceuticals SA
Profil
Stelios Spanos is currently the Director and VP-Sales & Marketing at Pharmathen Pharmaceuticals SA. He previously held the position of Director & VP-Sales and Marketing–Greek Market at Pharmathen SA and Director, Vice President-Sales & Marketing at Pharmathen International SA. Prior to his current role, he worked as a Commercial Director at Bayer Hellas AG.
Mr. Spanos completed his undergraduate degree at the University of Piraeus.
Postes actifs de Stelios Spanos
| Sociétés | Poste | Début |
|---|---|---|
Pharmathen Pharmaceuticals SA
 Pharmathen Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece. | Directeur/Membre du Conseil | - |
Pharmathen International SA
 Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Directeur/Membre du Conseil | 01/01/1994 |
Pharmathen SA
 Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Directeur/Membre du Conseil | 01/01/1994 |
Anciens postes connus de Stelios Spanos
| Sociétés | Poste | Fin |
|---|---|---|
| Bayer Hellas AG | Corporate Officer/Principal | - |
Formation de Stelios Spanos
| University of Piraeus | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Pharmathen Pharmaceuticals SA
Pharmathen Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece. | Health Technology |
Pharmathen SA
Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Health Technology |
| Bayer Hellas AG | |
Pharmathen International SA
Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Health Technology |
